Diagnosis of COVID-19 by Serology in Admitted Patients with Negative RT-PCR Assay

• Main Authors: Mitra Rezaei, Parvaneh Baghaei, Makan Sadr, Afshin Moniri, Abdolreza Babamahmoodi, Somayeh Qadimi, Mihan Porabdollah, Seyed Alireza Nadji, Payam Tabarsi, Majid Marjani
• Format: Article
• Language: English
• Published: Tehran University of Medical Sciences 2021-08-01
• Series: Iranian Journal of Allergy, Asthma and Immunology
• Subjects: Antibodies; COVID-19; Diagnosis; Reverse transcription polymerase chain reaction; Serology
• Online Access: https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2997

Considering the increasing prevalence and burden of coronavirus disease 2019 (COVID-19) disease and false-negative results in routine reverse transcription-polymerase chain reaction (RT-PCR) tests, additional diagnostic methods are needed to diagnose active cases of this disease. This prospective study was conducted on patients, in whom clinical and radiological symptoms/signs were in favor of COVID-19 while their first PCR test was negative. Later on, a second RT-PCR was performed and serological evaluation was carried out and results were compared with each other. Out of 707 patients who had been referred to the hospital and were clinically and radiologically suspicious of disease, 137 patients with negative RT-PCR tests entered the study. RT-PCR assay became positive for the second time in 45 (32.8%). Anti-COVID-19 IgM and IgG antibodies were positive in 83 (60.6%) and 86 (62.8%) patients, respectively. Finally, it was determined that serological test was diagnostic in 73% of patients and the diagnostic yield of serology was significantly higher after the first week of illness (54.8% in the first week and 88% after that). Taking advantage of both serological tests and RT-PCR helps in diagnosing 83.9% of cases. Based on the present study, the serology may be useful as a complementary test and in parallel to RT-PCR assay for diagnosis of COVID-19 among admitted symptomatic cases.